...
首页> 外文期刊>Microbes and infection >Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection
【24h】

Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection

机译:通过活性疫苗接种靶向凝固酶的R结构域保护小鼠免受致命葡萄球菌感染的影响

获取原文
获取原文并翻译 | 示例

摘要

Coagulase (Coa) secreted by Staphylococcus aureus is associated with the establishment of staphylococcal disease, which activates host prothrombin and generates fibrin shields. The R domain of Coa, consisting of several conserved repeats, is important in immune evasion during S. aureus infection. However, previous research showed that the Coa R domain induced very weak specific antibody responses. In this study, we constructed a new R domain, CoaR6, consisting of 6 repeats that occur most frequently in clinical isolates. By fusing CoaR6 with Hc, the C-terminal fragment of the heavy chain of tetanus neurotoxin, we successfully increased anti-CoaR6 IgG levels in immunized mice which were hardly detected in mice immunized with CoaR6 plus alum. To further improve anti-CoaR6 responses, the combination adjuvants alum plus CpG were formulated with the antigen and exhibited a significantly higher specific antibody response. Moreover, active Th1/Th17 immune responses were observed in Hc-CoaR6 immunized group rather than CoaR6. Active immunization of Hc-CoaR6 with alum plus CpG showed protective effects in a peritonitis model induced by two S. aureus strains with different coagulase types. Our results provided strategies to improve the immunogenicity of R domain and supporting evidences for R domain to be an S. aureus vaccine candidate. (C) 2018 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
机译:由金黄色葡萄球菌分泌的凝血酶(COA)与建立葡萄球菌疾病的建立有关,其激活宿主凝血酶蛋白并产生纤维蛋白屏蔽。 COA的R结构域包括几种保守的重复,在S. aureus感染期间的免疫逃避是重要的。然而,之前的研究表明,COA R结构域诱导非常弱的特异性抗体反应。在这项研究中,我们构建了一种新的R结构域,CoAR6,由6个重复组成,这些重复在临床分离物中最常见。通过用HC定影Coar6,Tetanus神经毒素的重链的C末端片段,我们成功地增加了免疫小鼠的抗CoAR6 IgG水平,几乎没有用Coar6加明矾免疫的小鼠中难以检测。为了进一步改善抗CoAR6反应,组合佐剂Alum Plus CpG与抗原配制,并表现出显着更高的特异性抗体反应。此外,在HC-CoAR6免疫基团中而不是CoAR6中观察到活性Th1 / Th17免疫应答。 HC-CoAR6具有Alum Plus CpG的活性免疫显示在具有不同凝结酶类型的两种金黄色葡萄球菌菌株诱导的腹膜炎模型中的保护作用。我们的结果提供了改善R结构域的免疫原性的策略,并为R域的支持证据成为Aureus疫苗候选人。 (c)2018年Institut Pasteur。由Elsevier Masson SA出版。版权所有。

著录项

  • 来源
    《Microbes and infection 》 |2019年第4期| 共7页
  • 作者单位

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

    Beijing Inst Biotechnol Lab Vaccine &

    Antibody Engn 20 Dongdajie St Beijing 100071 Peoples R;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学 ;
  • 关键词

    Staphylococcus aureus; Vaccine; Coagulase; Immunogenicity;

    机译:金黄色葡萄球菌;疫苗;凝血酶;免疫原性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号